{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:27:47Z","timestamp":1771946867164,"version":"3.50.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"F\u00e9d\u00e9ration Hospitalo-Universitaire Network of Research in Substance Use Disorders, Assistance Publique Hopitaux de Paris and Universit\u00e9 Paris Cit\u00e9, Paris, France","award":["F\u00e9d\u00e9ration Hospitalo-Universitaire Network of Research in Substance Use Disorders, Assistance Publique Hopitaux de Paris and Universit\u00e9 Paris Cit\u00e9, Paris, France"],"award-info":[{"award-number":["F\u00e9d\u00e9ration Hospitalo-Universitaire Network of Research in Substance Use Disorders, Assistance Publique Hopitaux de Paris and Universit\u00e9 Paris Cit\u00e9, Paris, France"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00213-024-06696-5","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T07:02:57Z","timestamp":1729494177000},"page":"2205-2222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the efficacy of cholinergic agents for the treatment of psychostimulant use disorder: a systematic review"],"prefix":"10.1007","volume":"241","author":[{"given":"Nicolas","family":"Salloum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Chouchana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Icick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Daumas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah El","family":"Mestikawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Vorspan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2803-8249","authenticated-orcid":false,"given":"Virgile","family":"Clergue-Duval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"6696_CR1","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1124\/jpet.107.119677","volume":"321","author":"MB Andersen","year":"2007","unstructured":"Andersen MB, Werge T, Fink-Jensen A (2007) The acetylcholinesterase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys. J Pharmacol Exp Ther 321:1179\u20131182. https:\/\/doi.org\/10.1124\/jpet.107.119677","journal-title":"J Pharmacol Exp Ther"},{"key":"6696_CR2","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/add.15237","volume":"116","author":"J Antoine","year":"2021","unstructured":"Antoine J, Berndt N, Astudillo M et al (2021) Cocaine treatment demands in 10 western European countries: observed trends between 2011 and 2018. Addiction 116:1131\u20131143. https:\/\/doi.org\/10.1111\/add.15237","journal-title":"Addiction"},{"key":"6696_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1152\/jn.2001.86.1.463","volume":"86","author":"N Barazangi","year":"2001","unstructured":"Barazangi N, Role LW (2001) Nicotine-induced enhancement of glutamatergic and GABAergic synaptic transmission in the mouse amygdala. J Neurophysiol 86:463\u2013474. https:\/\/doi.org\/10.1152\/jn.2001.86.1.463","journal-title":"J Neurophysiol"},{"key":"6696_CR4","doi-asserted-by":"publisher","first-page":"e218049","DOI":"10.1001\/jamanetworkopen.2021.8049","volume":"4","author":"BS Bentzley","year":"2021","unstructured":"Bentzley BS, Han SS, Neuner S et al (2021) Comparison of treatments for Cocaine Use Disorder among adults: a systematic review and Meta-analysis. JAMA Netw Open 4:e218049. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.8049","journal-title":"JAMA Netw Open"},{"key":"6696_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/s0306-4522(03)00378-6","volume":"120","author":"ML Berlanga","year":"2003","unstructured":"Berlanga ML, Olsen CM, Chen V et al (2003) Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. Neuroscience 120:1149\u20131156. https:\/\/doi.org\/10.1016\/s0306-4522(03)00378-6","journal-title":"Neuroscience"},{"key":"6696_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jamainternmed.2020.7850","volume":"181","author":"JC Black","year":"2021","unstructured":"Black JC, Bau GE, Iwanicki JL, Dart RC (2021) Association of medical stimulants with mortality in the US from 2010 to 2017. JAMA Intern Med 181:707\u2013709. https:\/\/doi.org\/10.1001\/jamainternmed.2020.7850","journal-title":"JAMA Intern Med"},{"key":"6696_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugalcdep.2018.04.023","volume":"189","author":"M Briones","year":"2018","unstructured":"Briones M, Shoptaw S, Cook R et al (2018) Varenicline treatment for methamphetamine dependence: a randomized, double-blind phase II clinical trial. Drug Alcohol Depend 189:30\u201336. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.023","journal-title":"Drug Alcohol Depend"},{"key":"6696_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jad.2012.05.006","volume":"143","author":"ES Brown","year":"2012","unstructured":"Brown ES, Gabrielson B (2012) A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence. J Affect Disord 143:257\u2013260. https:\/\/doi.org\/10.1016\/j.jad.2012.05.006","journal-title":"J Affect Disord"},{"key":"6696_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/JCP.0b013e31814db4c4","volume":"27","author":"ES Brown","year":"2007","unstructured":"Brown ES, Gorman AR, Hynan LS (2007) A Randomized, Placebo-Controlled Trial of Citicoline Add-On therapy in outpatients with bipolar disorder and Cocaine Dependence. J Clin Psychopharmacol 27:498\u2013502. https:\/\/doi.org\/10.1097\/JCP.0b013e31814db4c4","journal-title":"J Clin Psychopharmacol"},{"key":"6696_CR10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1176\/appi.ajp.2015.14070857","volume":"172","author":"ES Brown","year":"2015","unstructured":"Brown ES, Todd JP, Hu LT et al (2015) A Randomized, Double-Blind, placebo-controlled trial of Citicoline for Cocaine Dependence in Bipolar I disorder. Am J Psychiatry 172:1014\u20131021. https:\/\/doi.org\/10.1176\/appi.ajp.2015.14070857","journal-title":"Am J Psychiatry"},{"key":"6696_CR11","doi-asserted-by":"publisher","first-page":"775670","DOI":"10.3389\/fpsyt.2021.775670","volume":"12","author":"J Cab\u00e9","year":"2021","unstructured":"Cab\u00e9 J, Brousse G, Pereira B et al (2021) Influence of clinical markers of dopaminergic behaviors on depressive symptoms during Withdrawal in Cocaine users. Front Psychiatry 12:775670. https:\/\/doi.org\/10.3389\/fpsyt.2021.775670","journal-title":"Front Psychiatry"},{"issue":"1","key":"6696_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.celrep.2012.05.011","volume":"2","author":"R Cachope","year":"2012","unstructured":"Cachope R, Mateo Y, Mathur BN et al (2012) Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep 2(1):33\u201341. https:\/\/doi.org\/10.1016\/j.celrep.2012.05.011","journal-title":"Cell Rep"},{"key":"6696_CR13","unstructured":"Cadet-Ta\u00efrou A, Gandilhon M, G\u00e9rome C et al (2020) Changes in drug use and supply in France as seen through the TREND programme of the OFDT]. Observatoire Fran\u00e7ais des Drogues et des Toxicomanies, Paris, France, 1999\u20132019: Les mutations des usages et de l\u2019offre de drogues en France vues au travers du dispositif TREND de l\u2019OFDT [1999\u20132019"},{"key":"6696_CR15","doi-asserted-by":"publisher","first-page":"17m11669","DOI":"10.4088\/JCP.17m11669","volume":"79","author":"KM Carroll","year":"2018","unstructured":"Carroll KM, Nich C, DeVito EE et al (2018) Galantamine and computerized cognitive behavioral therapy for Cocaine Dependence: a Randomized Clinical Trial. J Clin Psychiatry 79:17m11669. https:\/\/doi.org\/10.4088\/JCP.17m11669","journal-title":"J Clin Psychiatry"},{"key":"6696_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/ajad.12904","volume":"28","author":"KM Carroll","year":"2019","unstructured":"Carroll KM, DeVito EE, Yip SW et al (2019) Double-blind Placebo\u2010Controlled Trial of Galantamine for Methadone\u2010maintained individuals with Cocaine Use Disorder: secondary analysis of effects on Illicit Opioid Use. Am J Addict 28:238\u2013245. https:\/\/doi.org\/10.1111\/ajad.12904","journal-title":"Am J Addict"},{"key":"6696_CR16","doi-asserted-by":"publisher","unstructured":"Clergue-Duval V, Lyonnet A, Azuar J et al (2024) Hospitalized cocaine detoxification patients in Paris, France: increased patient levels and changing population characteristics since 2011. Ther (in Press) S0040595724000386. https:\/\/doi.org\/10.1016\/j.therap.2024.03.001","DOI":"10.1016\/j.therap.2024.03.001"},{"key":"6696_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/1570159X11311030006","volume":"11","author":"MB Colovi\u0107","year":"2013","unstructured":"Colovi\u0107 MB, Krsti\u0107 DZ, Lazarevi\u0107-Pa\u0161ti TD et al (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 11:315\u2013335. https:\/\/doi.org\/10.2174\/1570159X11311030006","journal-title":"Curr Neuropharmacol"},{"key":"6696_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pbb.2007.12.010","volume":"89","author":"R De La Garza","year":"2008","unstructured":"De La Garza R, Mahoney JJ, Culbertson C et al (2008) The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol Biochem Behav 89:200\u2013208. https:\/\/doi.org\/10.1016\/j.pbb.2007.12.010","journal-title":"Pharmacol Biochem Behav"},{"key":"6696_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.pnpbp.2011.12.014","volume":"37","author":"R De La Garza","year":"2012","unstructured":"De La Garza R, Newton TF, Haile CN et al (2012) Rivastigmine reduces likely to use methamphetamine in methamphetamine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry 37:141\u2013146. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.12.014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6696_CR20","doi-asserted-by":"publisher","first-page":"pyv098","DOI":"10.1093\/ijnp\/pyv098","volume":"19","author":"R De La Garza","year":"2015","unstructured":"De La Garza R, Verrico CD, Newton TF et al (2015) Safety and preliminary efficacy of the acetylcholinesterase inhibitor huperzine A as a treatment for Cocaine Use Disorder. IJNPPY 19:pyv098. https:\/\/doi.org\/10.1093\/ijnp\/pyv098","journal-title":"IJNPPY"},{"key":"6696_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jsat.2019.08.009","volume":"107","author":"EE DeVito","year":"2019","unstructured":"DeVito EE, Carroll KM, Babuscio T et al (2019) Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder. J Subst Abuse Treat 107:29\u201337. https:\/\/doi.org\/10.1016\/j.jsat.2019.08.009","journal-title":"J Subst Abuse Treat"},{"key":"6696_CR22","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.euroneuro.2014.06.001","volume":"24","author":"LHJ Dieckmann","year":"2014","unstructured":"Dieckmann LHJ, Ramos AC, Silva EA et al (2014) Effects of biperiden on the treatment of cocaine\/crack addiction: a randomised, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 24:1196\u20131202. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.06.001","journal-title":"Eur Neuropsychopharmacol"},{"key":"6696_CR23","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.neuroscience.2008.07.052","volume":"156","author":"LK Dobbs","year":"2008","unstructured":"Dobbs LK, Mark GP (2008) Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse. Neuroscience 156:700\u2013711. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.07.052","journal-title":"Neuroscience"},{"key":"6696_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/fcp.12603","volume":"35","author":"C Eiden","year":"2021","unstructured":"Eiden C, Vincent M, Serrand C et al (2021) Health consequences of cocaine use in France: data from the French Addictovigilance Network. Fundam Clin Pharmacol 35:455\u2013465. https:\/\/doi.org\/10.1111\/fcp.12603","journal-title":"Fundam Clin Pharmacol"},{"key":"6696_CR27","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2022) European drug report 2022: trends and developments. Office for Official Publications of the European Communities, Lisbon. https:\/\/data.europa.eu\/doi\/10.2810\/75644. Accessed 18 August 2024"},{"key":"6696_CR26","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2023) European Drug Report 2023: Trend and Developments. Office for Official Publications of the European Communities, Lisbon. https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023_en. Accessed 18 August 2024"},{"key":"6696_CR29","doi-asserted-by":"publisher","first-page":"6616","DOI":"10.1172\/JCI138532","volume":"130","author":"M Favier","year":"2020","unstructured":"Favier M, Janickova H, Justo D et al (2020) Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating. J Clin Invest 130:6616\u20136630. https:\/\/doi.org\/10.1172\/JCI138532","journal-title":"J Clin Invest"},{"key":"6696_CR28","unstructured":"Favier M, Garcia EM, Icick R et al (2024) Study of the VGLUT3-pT8I mutation unravels common mechanisms of drug and food misuse and suggests potential treatment for anorexia-like behaviors in rodents. Nat Commun (in press)."},{"key":"6696_CR30","doi-asserted-by":"publisher","first-page":"101898","DOI":"10.1016\/j.pneurobio.2020.101898","volume":"197","author":"B Forget","year":"2021","unstructured":"Forget B, Icick R, Robert J et al (2021) Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients. Prog Neurobiol 197:101898. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101898","journal-title":"Prog Neurobiol"},{"key":"6696_CR31","doi-asserted-by":"publisher","unstructured":"Goldberg JA, Wilson CJ (2016) Chap. 7 - the Cholinergic Interneuron of the Striatum. In: Steiner H, Tseng KY (eds) Handbook of behavioral neuroscience. Elsevier, pp 137\u2013155. https:\/\/doi.org\/10.1016\/B978-0-12-802206-1.00007-6","DOI":"10.1016\/B978-0-12-802206-1.00007-6"},{"key":"6696_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugalcdep.2009.09.010","volume":"107","author":"K Grasing","year":"2010","unstructured":"Grasing K, Mathur D, Newton TF, DeSouza C (2010) Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. Drug Alcohol Depend 107:69\u201375. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.09.010","journal-title":"Drug Alcohol Depend"},{"key":"6696_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00008877-199302000-00001","volume":"4","author":"RR Griffiths","year":"1993","unstructured":"Griffiths RR, Troisi JR, Silverman K, Mumford GK (1993) Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 4:3\u201313","journal-title":"Behav Pharmacol"},{"key":"6696_CR34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.biopsych.2008.04.018","volume":"64","author":"RA Grucza","year":"2008","unstructured":"Grucza RA, Wang JC, Stitzel JA et al (2008) A risk allele for Nicotine Dependence in CHRNA5 is a protective allele for Cocaine Dependence. Biol Psychiatry 64:922\u2013929. https:\/\/doi.org\/10.1016\/j.biopsych.2008.04.018","journal-title":"Biol Psychiatry"},{"key":"6696_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0010-440X(91)90066-L","volume":"32","author":"JA Halikas","year":"1991","unstructured":"Halikas JA, Kuhn KL, Crosby R et al (1991) The measurement of craving in cocaine patients using the minnesota cocaine craving scale. Compr Psychiatry 32:22\u201327. https:\/\/doi.org\/10.1016\/0010-440X(91)90066-L","journal-title":"Compr Psychiatry"},{"key":"6696_CR36","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam M-M, Cuello AC et al (2018) The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain 141:1917\u20131933. https:\/\/doi.org\/10.1093\/brain\/awy132","journal-title":"Brain"},{"key":"6696_CR37","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ et al (2023) Chap. 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane. https:\/\/www.training.cochrane.org\/handbook. Accessed 18 August 2024"},{"key":"6696_CR38","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1073\/pnas.0631749100","volume":"100","author":"T Hikida","year":"2003","unstructured":"Hikida T, Kitabatake Y, Pastan I, Nakanishi S (2003) Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci U S A 100:6169\u20136173. https:\/\/doi.org\/10.1073\/pnas.0631749100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6696_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/s0006-8993(02)03692-2","volume":"958","author":"J Ichikawa","year":"2002","unstructured":"Ichikawa J, Chung YC, Li Z et al (2002) Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res 958:176\u2013184. https:\/\/doi.org\/10.1016\/s0006-8993(02)03692-2","journal-title":"Brain Res"},{"key":"6696_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpsychires.2021.09.006","volume":"143","author":"H Jeong","year":"2021","unstructured":"Jeong H, Yoon S, Sung Y-H et al (2021) Effects of cytidine-5\u2032-diphosphate choline on gray matter volumes in methamphetamine-dependent patients: a randomized, double-blind, placebo-controlled study. J Psychiatr Res 143:215\u2013221. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.09.006","journal-title":"J Psychiatr Res"},{"key":"6696_CR41","doi-asserted-by":"publisher","first-page":"173725","DOI":"10.1016\/j.pbb.2024.173725","volume":"237","author":"MSC Junior","year":"2024","unstructured":"Junior MSC, Bezerra AG, Curado DF et al (2024) Preliminary investigation of the administration of biperiden to reduce relapses in individuals with cocaine\/crack user disorder: a randomized controlled clinical trial. Pharmacol Biochem Behav 237:173725. https:\/\/doi.org\/10.1016\/j.pbb.2024.173725","journal-title":"Pharmacol Biochem Behav"},{"key":"6696_CR42","doi-asserted-by":"publisher","first-page":"106705","DOI":"10.1016\/j.phrs.2023.106705","volume":"190","author":"HM Kamens","year":"2023","unstructured":"Kamens HM, Flarend G, Horton WJ (2023) The role of nicotinic receptors in alcohol consumption. Pharmacol Res 190:106705. https:\/\/doi.org\/10.1016\/j.phrs.2023.106705","journal-title":"Pharmacol Res"},{"key":"6696_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0306-4603(98)00011-2","volume":"23","author":"KM Kampman","year":"1998","unstructured":"Kampman KM, Volpicelli JR, Mcginnis DE et al (1998) Reliability and validity of the cocaine selective severity assessment. Addict Behav 23:449\u2013461. https:\/\/doi.org\/10.1016\/S0306-4603(98)00011-2","journal-title":"Addict Behav"},{"key":"6696_CR44","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1046\/j.1460-9568.1999.00788.x","volume":"11","author":"N Kayadjanian","year":"1999","unstructured":"Kayadjanian N, Schofield WN, Andren J et al (1999) Cortical and nigral deafferentation and striatal cholinergic markers in the rat dorsal striatum: different effects on the expression of mRNAs encoding choline acetyltransferase and muscarinic m1 and m4 receptors. Eur J Neurosci 11:3659\u20133668. https:\/\/doi.org\/10.1046\/j.1460-9568.1999.00788.x","journal-title":"Eur J Neurosci"},{"key":"6696_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0021-9258(19)50785-2","volume":"222","author":"EP Kennedy","year":"1956","unstructured":"Kennedy EP, Weiss SB (1956) The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem 222:193\u2013214","journal-title":"J Biol Chem"},{"key":"6696_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-023-05995-9","volume":"621","author":"AC Krok","year":"2023","unstructured":"Krok AC, Maltese M, Mistry P et al (2023) Intrinsic dopamine and acetylcholine dynamics in the striatum of mice. Nature 621:543\u2013549. https:\/\/doi.org\/10.1038\/s41586-023-05995-9","journal-title":"Nature"},{"key":"6696_CR47","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/brainsci12111546","volume":"12","author":"DLS Lassi","year":"2022","unstructured":"Lassi DLS, Malbergier A, Negr\u00e3o AB et al (2022) Pharmacological treatments for Cocaine craving: what is the Way Forward? A systematic review. Brain Sci 12:1546. https:\/\/doi.org\/10.3390\/brainsci12111546","journal-title":"Brain Sci"},{"key":"6696_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/ADM.0b013e3181d80c93","volume":"5","author":"SC Licata","year":"2011","unstructured":"Licata SC, Penetar DM, Ravichandran C et al (2011) Effects of Daily Treatment with Citicoline: a Double-Blind, placebo-controlled study in Cocaine-Dependent volunteers. J Addict Med 5:57\u201364. https:\/\/doi.org\/10.1097\/ADM.0b013e3181d80c93","journal-title":"J Addict Med"},{"issue":"6587","key":"6696_CR49","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1126\/science.abn0532","volume":"375","author":"C Liu","year":"2022","unstructured":"Liu C, Cai X, Ritzau-Jost A et al (2022) An action potential initiation mechanism in distal axons for the control of dopamine release. Science 375(6587):1378\u20131385. https:\/\/doi.org\/10.1126\/science.abn0532","journal-title":"Science"},{"key":"6696_CR50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/ADM.0000000000000842","volume":"16","author":"KG Lynch","year":"2022","unstructured":"Lynch KG, Plebani J, Spratt K et al (2022) Varenicline for the treatment of Cocaine Dependence. J Addict Med 16:157\u2013163. https:\/\/doi.org\/10.1097\/ADM.0000000000000842","journal-title":"J Addict Med"},{"key":"6696_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1023\/B:CEMN.0000012718.08443.60","volume":"24","author":"DS Mac\u00eado","year":"2004","unstructured":"Mac\u00eado DS, Correia EE, Vasconcelos SMM et al (2004) Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors. Cell Mol Neurobiol 24:129\u2013136. https:\/\/doi.org\/10.1023\/B:CEMN.0000012718.08443.60","journal-title":"Cell Mol Neurobiol"},{"key":"6696_CR52","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1300\/J069v20n03_07","volume":"20","author":"JP Mezinskis","year":"2001","unstructured":"Mezinskis JP, Honos-Webb L, Kropp F, Somoza E (2001) The measurement of craving. J Addict Dis 20:67\u201385. https:\/\/doi.org\/10.1300\/J069v20n03_07","journal-title":"J Addict Dis"},{"key":"6696_CR53","doi-asserted-by":"publisher","first-page":"104482","DOI":"10.1016\/j.neuint.2019.104482","volume":"129","author":"S Mingote","year":"2019","unstructured":"Mingote S, Amsellem A, Kempf A et al (2019) Dopamine-glutamate Neuron projections to the Nucleus Accumbens Medial Shell and behavioral switching. Neurochem Int 129:104482. https:\/\/doi.org\/10.1016\/j.neuint.2019.104482","journal-title":"Neurochem Int"},{"key":"6696_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fpsyt.2016.00030","volume":"7","author":"I Oliva","year":"2016","unstructured":"Oliva I, Wanat MJ (2016) Ventral tegmental area afferents and drug-dependent behaviors. Front Psychiatry 7:30. https:\/\/doi.org\/10.3389\/fpsyt.2016.00030","journal-title":"Front Psychiatry"},{"key":"6696_CR55","doi-asserted-by":"publisher","first-page":"172758","DOI":"10.1016\/j.pbb.2019.172758","volume":"185","author":"M Patel","year":"2019","unstructured":"Patel M, Verrico CD, De La Garza R (2019) Rivastigmine does not alter cocaine-induced subjective effects or self-administration. Pharmacol Biochem Behav 185:172758. https:\/\/doi.org\/10.1016\/j.pbb.2019.172758","journal-title":"Pharmacol Biochem Behav"},{"key":"6696_CR56","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1523\/JNEUROSCI.22-09-03338.2002","volume":"22","author":"MR Picciotto","year":"2002","unstructured":"Picciotto MR, Corrigall WA (2002) Neuronal systems underlying behaviors related to Nicotine Addiction: neural circuits and Molecular Genetics. J Neurosci 22:3338\u20133341. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-09-03338.2002","journal-title":"J Neurosci"},{"key":"6696_CR57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.drugalcdep.2011.08.025","volume":"121","author":"JG Plebani","year":"2012","unstructured":"Plebani JG, Lynch KG, Yu Q et al (2012) Results of an initial clinical trial of varenicline for the treatment of cocaine dependence. Drug Alcohol Depend 121:163\u2013166. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.08.025","journal-title":"Drug Alcohol Depend"},{"key":"6696_CR58","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1521-0391.2010.00066.x","volume":"19","author":"J Poling","year":"2010","unstructured":"Poling J, Rounsaville B, Gonsai K et al (2010) The Safety and Efficacy of Varenicline in Cocaine using smokers maintained on Methadone: a pilot study. Am J Addict 19:401\u2013408. https:\/\/doi.org\/10.1111\/j.1521-0391.2010.00066.x","journal-title":"Am J Addict"},{"key":"6696_CR59","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0893-133X(98)00076-1","volume":"20","author":"MS Reid","year":"1999","unstructured":"Reid MS (1999) A Nicotine antagonist, mecamylamine, reduces Cue-Induced Cocaine craving in Cocaine-dependent subjects. Neuropsychopharmacology 20:297\u2013307. https:\/\/doi.org\/10.1016\/S0893-133X(98)00076-1","journal-title":"Neuropsychopharmacology"},{"key":"6696_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0376-8716(97)00144-0","volume":"49","author":"MS Reid","year":"1998","unstructured":"Reid MS, Mickalian JD, Delucchi KL et al (1998) An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend 49:95\u2013104. https:\/\/doi.org\/10.1016\/S0376-8716(97)00144-0","journal-title":"Drug Alcohol Depend"},{"key":"6696_CR60","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1300\/J465v26n02_02","volume":"26","author":"MS Reid","year":"2005","unstructured":"Reid MS, Angrist B, O\u2019Leary S et al (2005) A placebo controlled, Double-Blind Study of Mecamylamine Treatment for Cocaine Dependence in patients enrolled in an opiate replacement program. Subst Abus 26:5\u201314. https:\/\/doi.org\/10.1300\/J465v26n02_02","journal-title":"Subst Abus"},{"key":"6696_CR62","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s002130050871","volume":"142","author":"PF Renshaw","year":"1999","unstructured":"Renshaw PF, Daniels S, Lundahl LH et al (1999) Short-term treatment with citicoline (CDP-choline) attenuates some measures of craving in cocaine-dependent subjects: a preliminary report. Psychopharmacology 142:132\u2013138. https:\/\/doi.org\/10.1007\/s002130050871","journal-title":"Psychopharmacology"},{"key":"6696_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2156-9-58","volume":"9","author":"NL Saccone","year":"2008","unstructured":"Saccone NL, Saccone SF, Goate AM et al (2008) In search of causal variants: refining disease association signals using cross-population contrasts. BMC Genet 9:58. https:\/\/doi.org\/10.1186\/1471-2156-9-58","journal-title":"BMC Genet"},{"key":"6696_CR64","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.33588\/rn.75s05.2022311","volume":"75","author":"JJ Secades","year":"2022","unstructured":"Secades JJ, Gareri P (2022) Citicoline: pharmacological and clinical review, 2022 update. Rev Neurol 75:S1\u2013S89. https:\/\/doi.org\/10.33588\/rn.75s05.2022311","journal-title":"Rev Neurol"},{"key":"6696_CR65","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.neuroscience.2010.07.028","volume":"170","author":"S Shabani","year":"2010","unstructured":"Shabani S, Foster R, Gubner N et al (2010) Muscarinic type 2 receptors in the lateral dorsal tegmental area modulate cocaine and food seeking behavior in rats. Neuroscience 170:559\u2013569. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.07.028","journal-title":"Neuroscience"},{"key":"6696_CR66","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/npp.2010.64","volume":"35","author":"R Sherva","year":"2010","unstructured":"Sherva R, Kranzler HR, Yu Y et al (2010) Variation in nicotinic acetylcholine receptor genes is Associated with multiple substance dependence phenotypes. Neuropsychopharmacol 35:1921\u20131931. https:\/\/doi.org\/10.1038\/npp.2010.64","journal-title":"Neuropsychopharmacol"},{"key":"6696_CR67","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/sj.npp.1300415","volume":"29","author":"B-FX Sobel","year":"2004","unstructured":"Sobel B-FX, Sigmon SC, Griffiths RR (2004) Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of Intravenous Nicotine, but not Cocaine or Caffeine, in cigarette-smoking stimulant abusers. Neuropsychopharmacol 29:991\u20131003. https:\/\/doi.org\/10.1038\/sj.npp.1300415","journal-title":"Neuropsychopharmacol"},{"key":"6696_CR68","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1521-0391.2011.00130.x","volume":"20","author":"M Sofuoglu","year":"2011","unstructured":"Sofuoglu M, Carroll KM (2011) Effects of Galantamine on Cocaine Use in Chronic Cocaine users: Galantamine and Cocaine Use. Am J Addict 20:302\u2013303. https:\/\/doi.org\/10.1111\/j.1521-0391.2011.00130.x","journal-title":"Am J Addict"},{"key":"6696_CR69","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:125504","volume-title":"Estimates of drug overdose deaths involving fentanyl, methamphetamine, cocaine, heroin, and oxycodone: United States, 2021","author":"MR Spencer","year":"2023","unstructured":"Spencer MR, Warner M, Cisewski JA et al (2023) Estimates of drug overdose deaths involving fentanyl, methamphetamine, cocaine, heroin, and oxycodone: United States, 2021. National Center for Health Statistics, Hyattsville, MD"},{"key":"6696_CR70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12873-022-00573-0","volume":"22","author":"LW Suen","year":"2022","unstructured":"Suen LW, Davy-Mendez T, LeSaint KT et al (2022) Emergency department visits and trends related to cocaine, psychostimulants, and opioids in the United States, 2008\u20132018. BMC Emerg Med 22:19. https:\/\/doi.org\/10.1186\/s12873-022-00573-0","journal-title":"BMC Emerg Med"},{"key":"6696_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnsys.2011.00011","volume":"5","author":"S Threlfell","year":"2011","unstructured":"Threlfell S, Cragg SJ (2011) Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. Front Syst Neurosci 5:11. https:\/\/doi.org\/10.3389\/fnsys.2011.00011","journal-title":"Front Syst Neurosci"},{"key":"6696_CR71","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1523\/JNEUROSCI.5620-09.2010","volume":"30","author":"S Threlfell","year":"2010","unstructured":"Threlfell S, Clements MA, Khodai T et al (2010) Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci 30:3398\u20133408. https:\/\/doi.org\/10.1523\/JNEUROSCI.5620-09.2010","journal-title":"J Neurosci"},{"issue":"1","key":"6696_CR73","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuron.2012.04.038","volume":"75","author":"S Threlfell","year":"2012","unstructured":"Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, Cragg SJ (2012) Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75(1):58\u201364. https:\/\/doi.org\/10.1016\/j.neuron.2012.04.038","journal-title":"Neuron"},{"key":"6696_CR74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0376-8716(93)90042-O","volume":"34","author":"ST Tiffany","year":"1993","unstructured":"Tiffany ST, Singleton E, Haertzen CA, Henningfield JE (1993) The development of a cocaine craving questionnaire. Drug Alcohol Depend 34:19\u201328. https:\/\/doi.org\/10.1016\/0376-8716(93)90042-O","journal-title":"Drug Alcohol Depend"},{"key":"6696_CR75","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1017\/S146114571300134X","volume":"17","author":"CD Verrico","year":"2014","unstructured":"Verrico CD, Mahoney JJ, Thompson-Lake DGY et al (2014) Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharm 17:223\u2013233. https:\/\/doi.org\/10.1017\/S146114571300134X","journal-title":"Int J Neuropsychopharm"},{"key":"6696_CR76","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1152\/physrev.00014.2018","volume":"99","author":"ND Volkow","year":"2019","unstructured":"Volkow ND, Michaelides M, Baler R (2019) The neuroscience of drug reward and addiction. Physiol Rev 99:2115\u20132140. https:\/\/doi.org\/10.1152\/physrev.00014.2018","journal-title":"Physiol Rev"},{"key":"6696_CR77","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/sj.npp.1301585","volume":"33","author":"MJ Williams","year":"2008","unstructured":"Williams MJ, Adinoff B (2008) The role of Acetylcholine in Cocaine Addiction. Neuropsychopharmacol 33:1779\u20131797. https:\/\/doi.org\/10.1038\/sj.npp.1301585","journal-title":"Neuropsychopharmacol"},{"key":"6696_CR78","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1360-0443.2005.00992.x","volume":"100","author":"TM Winhusen","year":"2005","unstructured":"Winhusen TM, Somoza EC, Harrer JM et al (2005) A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100:68\u201377. https:\/\/doi.org\/10.1111\/j.1360-0443.2005.00992.x","journal-title":"Addiction"},{"key":"6696_CR79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-psych-010418-103337","volume":"71","author":"RA Wise","year":"2020","unstructured":"Wise RA, Robble MA (2020) Dopamine and addiction. Annu Rev Psychol 71:79\u2013106. https:\/\/doi.org\/10.1146\/annurev-psych-010418-103337","journal-title":"Annu Rev Psychol"},{"key":"6696_CR80","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/10550499509038111","volume":"4","author":"EJ Wiseman","year":"1995","unstructured":"Wiseman EJ, McMillan DE (1995) Transdermal nicotine and drug craving. Am J Addict 4:261\u2013266. https:\/\/doi.org\/10.3109\/10550499509038111","journal-title":"Am J Addict"},{"key":"6696_CR81","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/npp.2009.221","volume":"35","author":"SJ Yoon","year":"2010","unstructured":"Yoon SJ, Lyoo IK, Kim HJ et al (2010) Neurochemical alterations in methamphetamine-dependent patients treated with Cytidine-5\u2032-Diphosphate choline: a longitudinal Proton magnetic resonance spectroscopy study. Neuropsychopharmacol 35:1165\u20131173. https:\/\/doi.org\/10.1038\/npp.2009.221","journal-title":"Neuropsychopharmacol"},{"issue":"36","key":"6696_CR82","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.1523\/JNEUROSCI.0694-08.2008","volume":"28","author":"ZB You","year":"2008","unstructured":"You ZB, Wang B, Zitzman D, Wise RA (2008) Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation. J Neurosci 28(36):9021\u20139029. https:\/\/doi.org\/10.1523\/JNEUROSCI.0694-08.2008","journal-title":"J Neurosci"},{"key":"6696_CR83","doi-asserted-by":"publisher","first-page":"e49368","DOI":"10.1371\/journal.pone.0049368","volume":"8","author":"T Zayats","year":"2013","unstructured":"Zayats T, Yang B-Z, Xie P et al (2013) A Complex interplay between personality domains, Marital Status and a variant in CHRNA5 on the risks of Cocaine, Nicotine dependences and Cocaine-Induced paranoia. PLoS ONE 8:e49368. https:\/\/doi.org\/10.1371\/journal.pone.0049368","journal-title":"PLoS ONE"},{"key":"6696_CR84","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0006-8993(91)90655-F","volume":"552","author":"S Zeigler","year":"1991","unstructured":"Zeigler S, Lipton J, Toga A, Ellison G (1991) Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior. Brain Res 552:27\u201335. https:\/\/doi.org\/10.1016\/0006-8993(91)90655-F","journal-title":"Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-024-06696-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-024-06696-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:44:34Z","timestamp":1730105074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-024-06696-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["6696"],"URL":"https:\/\/doi.org\/10.1007\/s00213-024-06696-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"11 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RI performed a paid talk for PIERRE FABRE, with the payment transferred in full to a non-profit association. The others authors declare that they have no competing interest that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}